News

BioSpace16h
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
Axios on MSN6d
Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.
Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...
BioPharma Dive6d
Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
STAT8d
Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA
Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied ...
STAT7d
Vinay Prasad is outraged, and now at the FDA. How will biotech deal?
Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...
STAT6d
New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff
WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...
Bloomberg L.P.1d
FDA Appointee Is a Notorious Drug Critic With a Lot to Prove
Previously, she was executive editor of Chemical & Engineering News. The controversial appointment of oncologist Vinay Prasad — an outspoken critic of the pharmaceutical industry and US health ...
FDA names Dr. Vinay Prasad as top vaccine official
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
MedPage Today on MSN8d
Vinay Prasad, Critic of COVID Measures, Picked as FDA's Top Vaccine Official
Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next ...
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
STAT8d
Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out.